ProCardio spring meeting 2024
The annual spring meeting were to be held at St.Olavs Hospital/NTNU in Trondheim on April 25th. However, due to an Avinor error that closed the entire airspace in Southern Norway, the meeting had to be held both physically and with remote participation from Oslo/Horten.
Speed updates
Richard Cornelussen presented NeuECG. The background is that NeuECG can measure activity from sympathetic fibers in the skin in a non-invasive way. It has been seen that the sympathetic nervous system is activated before ventricular tachycardia or ventricular fibrillation, and NeuECG can thus be thought to have clinical utility by predicting dangerous arrhythmias.
Morgan Jacobsen presented the cardiooncology dashboard. This is a kind of web-based screen adapted to patients with cancer receiving cardiotoxic chemotherapy. In the screen, you can fill in various information about the patient, for example treatment received, previous cardiac diseases, findings by echocardiography and so on. With such a compilation, it is possible, for example, to detect a falling ejection fraction at an earlier time.
Bendik Skinningsrud presented his PhD project on vaccine-induced myocarditis. In connection with the covid-19 pandemic, effective vaccines were quickly developed, but these can have unfortunate side effects. In particularly young patients, it is important to discover whether the side effects, for example myocarditis, mean that the vaccine practice should be changed.
Cecilie Bugge spoke about arrhythmic mitral valve prolapse, and the latest knowledge in the area. She also presented the ongoing FLECAPRO study, where treatment with flecainide is tested on patients with arrhythmic mitral valve prolapse.
Large language models – useful in echocardiography?
Svein Arne Aase had a presentation on large language models, and whether these can be useful in echocardiography. One can imagine several areas of use, for example in connection with troubleshooting. A next step could also be, for example, feeding echocardiography images into the model and using new technology to see if the images are good enough.